Dis-Chem expects bump in profit amid controversy
Union Solidarity says it will take Dis-Chem to court after it missed a deadline to respond to a question about race-based hiring practices
24 October 2022 - 09:46
Dis-Chem is expecting a bump in its headline earnings in its interim results — a bit of good news for the pharmacy chain that is dealing with an intensifying outcry about a letter from the CEO placing a moratorium on employing white people.
The company, valued at R27.2bn on the JSE, said in a trading statement on Monday that it expects its headline earnings per share (Heps), a widely used measure of profit that strips out impairments and one-off items, to increase 43.1%-45.4% to 69.7c — 70.8c in its results end-August...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.